" /> t(3;5)(q25.1;q35.1)(MLF1,NPM1) fusion transcript:Arb:Pt:Bld/Tiss:Ord:Molgen - CISMeF





Preferred Label : t(3;5)(q25.1;q35.1)(MLF1,NPM1) fusion transcript:Arb:Pt:Bld/Tiss:Ord:Molgen;

LOINC status : ACTIVE;

LOINC display name : t(3;5)(q25.1;q35.1)(MLF1,NPM1) fusion transcript Molgen Ql (Bld/Tiss);

LOINC long common name : t(3;5)(q25.1;q35.1)(MLF1,NPM1) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method;

LOINC short name : t(3;5)(MLF1,NPM1) Bld/T Ql;

LOINC description : This term is used to identify a leukemia causing chromosomal translocation resulting in a gene fusion between MLF1 (3q25.1) and NPM1 (5q34) genes. The term was created for (but not limited to) DNA Technology's HemaVision HV01-28N kit, a qualitative in vitro diagnostic test for 28 leukemia causing chromosomal alterations including more than 80 breakpoints plus associated mRNA splice variants. Reverse transcription followed by multiplex nested polymerase chain reactions (RT-PCR) and agarose gel electrophoresis are used to identify gene fusions caused by chromosomal translocations, gene deletions or inversions. Testing information is useful for predicting development of the disease and selection of treatment.;

Details


You can consult :


Nous contacter.
29/04/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.